UY28189A1 - Sistema terapéutico transdérmico estable a los rayos uv. - Google Patents

Sistema terapéutico transdérmico estable a los rayos uv.

Info

Publication number
UY28189A1
UY28189A1 UY28189A UY28189A UY28189A1 UY 28189 A1 UY28189 A1 UY 28189A1 UY 28189 A UY28189 A UY 28189A UY 28189 A UY28189 A UY 28189A UY 28189 A1 UY28189 A1 UY 28189A1
Authority
UY
Uruguay
Prior art keywords
therapeutic system
transdermal therapeutic
rays
system stable
tts
Prior art date
Application number
UY28189A
Other languages
English (en)
Inventor
Jochen Schuhmacher
Michael Dittgen
Manfred Susse
Stephan Mletzko
Jan-Peter Ingwersen
Dirk Schenk
Thomas Langguth
Hubert Kaffl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP03003888A external-priority patent/EP1449526A1/de
Priority claimed from EP03004061A external-priority patent/EP1452173A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of UY28189A1 publication Critical patent/UY28189A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Nuevo sistema terapéutico transdérmico estable a los rayos UV (TTS) que consiste en una capa de base, por lo menos una matriz que contiene sustancia activa y opcionalmente una película despegable y además un agente absorbedor de rayos UV. El sistema terapéutico transdérmico de la invención posee gran estabilidad y no tiene las desventajas de los TTS que contienen sustancias activas sensibles a la luz tradicionales.
UY28189A 2003-02-21 2004-02-17 Sistema terapéutico transdérmico estable a los rayos uv. UY28189A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03003888A EP1449526A1 (de) 2003-02-21 2003-02-21 UV-stabiles transdermales Pflaster
EP03004061A EP1452173A1 (de) 2003-02-25 2003-02-25 UV-stabiles transdermales Pflaster

Publications (1)

Publication Number Publication Date
UY28189A1 true UY28189A1 (es) 2004-04-30

Family

ID=32910125

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28189A UY28189A1 (es) 2003-02-21 2004-02-17 Sistema terapéutico transdérmico estable a los rayos uv.

Country Status (31)

Country Link
US (3) US8486443B2 (es)
EP (1) EP1594483B1 (es)
JP (1) JP4528296B2 (es)
KR (1) KR100704825B1 (es)
AR (1) AR043248A1 (es)
AT (1) ATE333271T1 (es)
AU (1) AU2004212675B2 (es)
BR (1) BRPI0407615B8 (es)
CA (1) CA2515918C (es)
CR (1) CR7952A (es)
CY (1) CY1105716T1 (es)
DE (1) DE502004000988D1 (es)
DK (1) DK1594483T3 (es)
EA (1) EA008098B1 (es)
EC (1) ECSP056030A (es)
ES (1) ES2270345T3 (es)
HK (1) HK1085394A1 (es)
HR (1) HRP20050828B1 (es)
IL (1) IL170295A (es)
IS (1) IS2541B (es)
ME (2) MEP14008A (es)
MX (1) MXPA05008778A (es)
NO (1) NO336108B1 (es)
NZ (1) NZ541807A (es)
PE (1) PE20041028A1 (es)
PL (1) PL219030B1 (es)
PT (1) PT1594483E (es)
RS (1) RS50428B (es)
SI (1) SI1594483T1 (es)
UY (1) UY28189A1 (es)
WO (1) WO2004073696A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2515918C (en) 2003-02-21 2010-11-16 Schering Ag Uv stable transdermal therapeutic plaster
US8668925B2 (en) * 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
EP1796651B1 (en) * 2004-08-20 2015-05-20 3M Innovative Properties Company Transdermal drug delivery device with translucent protective film
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
EP1719504A1 (de) * 2005-05-02 2006-11-08 Schering AG Festes transdermales therapeutisches System mit UV-Absorber
JP2011528038A (ja) * 2008-07-14 2011-11-10 サーモディクス，インコーポレイテッド 医療用デバイスおよび核酸の送達方法
WO2012031999A2 (en) * 2010-09-06 2012-03-15 Bayer Pharma Aktiengesellschaft Low-dose transdermal patches with high drug release
DE102010040299A1 (de) * 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
MX2018008190A (es) 2015-12-30 2018-11-12 Corium Int Inc Sistemas y metodos para la administracion transdermica a largo plazo.
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
DE102020104907A1 (de) * 2020-02-25 2021-08-26 Berliner Glas GmbH Verfahren zur Herstellung eines Bauelements durch atomares Diffusionsbonden

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5939827A (ja) 1982-08-27 1984-03-05 Nitto Electric Ind Co Ltd 医療用外用部材
JPS6069014A (ja) 1983-09-27 1985-04-19 Nitto Electric Ind Co Ltd 皮膚疾患治療用貼付剤
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
JPS60166611A (ja) 1984-02-10 1985-08-29 Nitto Electric Ind Co Ltd 疾患治療用部材
US5560922A (en) 1986-05-30 1996-10-01 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
US5023084A (en) 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
CH674618A5 (es) 1987-04-02 1990-06-29 Ciba Geigy Ag
US5538736A (en) 1987-04-28 1996-07-23 Lts Lohmann Therapie-Systeme Gmbh Active substance-containing plaster for the controlled administration of active substances to the skin
US5128284A (en) 1987-10-23 1992-07-07 Allied-Signal Inc. Preparation of lanthanum chromite powders by sol-gel
HU210549B (en) 1988-10-27 1995-05-29 Schering Ag Process for producing transdermally applicable pharmaceutical composition containing gestodene
DE59107052D1 (de) 1990-03-30 1996-01-25 Ciba Geigy Ag Lackzusammensetzungen
DE69108512T2 (de) 1990-05-17 1995-08-03 Hisamitsu Pharmaceutical Co Estradiol enthaltende transdermale zubereitung.
GB9021674D0 (en) 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
MX9101787A (es) 1990-10-29 1992-06-05 Alza Corp Formulaciones,metodos y dispositivos anticonceptivos transdermicos
US5512292A (en) 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
JP3112707B2 (ja) 1991-07-25 2000-11-27 日本電気株式会社 監視システム用ポーリング方式
DE4336557C2 (de) 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4329242A1 (de) * 1993-08-26 1995-03-02 Schering Ag Mittel zur transdermalen Applikation enthaltend Gestodenester
DE4336299A1 (de) * 1993-10-25 1995-05-11 Arbo Robotron Medizin Technolo Gelkörper zur percutanen Verabreichung, insbesondere von Medikamenten
DE4403487C2 (de) 1994-02-04 2003-10-16 Lohmann Therapie Syst Lts Arznei-Pflaster mit UV-vernetzbaren Acrylat-Copolymeren
DE4405898A1 (de) 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
EP0787488A4 (en) 1994-11-18 1998-06-03 Hisamitsu Pharmaceutical Co TRANSDERMAL ABSORBABLE PLASTER
JP3908795B2 (ja) 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
UA48973C2 (uk) 1995-06-07 2002-09-16 Орто-Макнейл Фармасьютікалз Інк. Трансдермальний пластир на основі 17-деацетилноргестимату для попередження овуляції
US5906830A (en) 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
JP3626275B2 (ja) 1996-04-09 2005-03-02 Ｊｓｒ株式会社 光硬化性樹脂組成物
US5762956A (en) 1996-04-24 1998-06-09 Rutgers, The State University Of New Jersey Transdermal contraceptive delivery system and process
JP4346696B2 (ja) 1996-05-28 2009-10-21 久光製薬株式会社 経皮治療用装置
JP3434135B2 (ja) 1996-07-11 2003-08-04 アルパイン株式会社 ナビゲーション装置
DE19701949A1 (de) 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
JPH10265371A (ja) * 1997-03-25 1998-10-06 Sekisui Chem Co Ltd 経皮吸収貼付剤
BR9808594A (pt) 1997-04-16 2000-05-23 Hisamitsu Pharmaceutical Co Composição substrato para absorção percutânea, e, preparação de absorção percutânea.
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
DE19827732A1 (de) 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
JP4399044B2 (ja) 1998-10-14 2010-01-13 久光製薬株式会社 吸収促進剤及び該吸収促進剤を有してなる経皮吸収製剤
AU3478200A (en) 1999-02-02 2000-08-25 Ortho-Mcneil Pharmaceutical, Inc. Method of manufacture for transdermal matrices
DE19906152B4 (de) 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
DE19912623A1 (de) 1999-03-20 2000-09-28 Lohmann Therapie Syst Lts Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile
US8173592B1 (en) 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
KR20010112479A (ko) 1999-07-01 2001-12-20 나까도미 히로다카 경피흡수 첩부제
WO2001037770A1 (en) 1999-11-24 2001-05-31 Agile Therapeutics, Inc. Improved transdermal contraceptive delivery system and process
AU3104301A (en) 2000-01-20 2001-07-31 Noven Pharmaceuticals, Inc. Compositions and methods to effect the release profile in the transdermal administration of active agents
EP1269999B1 (en) 2000-03-17 2013-05-01 Hisamitsu Pharmaceutical Co. Inc. Ultraviolet-shielding patch
AU2001264256B2 (en) * 2000-06-13 2006-05-11 Hisamitsu Pharmaceutical Co, Inc Plaster
DE10053375C1 (de) 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
TWI287455B (en) 2000-12-05 2007-10-01 Noven Pharma Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use
CN1652797A (zh) 2002-03-11 2005-08-10 詹森药业有限公司 连续使用抑制硫酸酯酶的孕激素的避孕给药方案
US6872401B2 (en) 2002-03-28 2005-03-29 L'oreal Cosmetic/dermatological compositions comprising a tetrahydrocurcuminoid and an amide oil
US7470452B1 (en) 2002-06-13 2008-12-30 E. I. Du Pont De Nemours & Company Process for multilayer coating of substrates
US7032980B2 (en) * 2002-06-27 2006-04-25 The Little Tikes Company Non-slip wheel for a child's toy
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
EP1452173A1 (de) 2003-02-25 2004-09-01 Schering AG UV-stabiles transdermales Pflaster
CA2515918C (en) 2003-02-21 2010-11-16 Schering Ag Uv stable transdermal therapeutic plaster
US8524272B2 (en) * 2003-08-15 2013-09-03 Mylan Technologies, Inc. Transdermal patch incorporating active agent migration barrier layer
DE602004018156D1 (de) 2003-08-25 2009-01-15 Bfs Diversified Products Llc Verfahren und vorrichtung zur überwachung der druckfestigkeit von isolierplatten
BRPI0414249B1 (pt) 2003-09-11 2013-08-06 dispersão polimérica aquosa concentrada, processo para a preparação da referida dispersão, pó de polímero, composição estabilizada e de revestimento em pó estabilizada, bem como uso da referida dispersão de polímero e do pó de polímero
US20050129756A1 (en) 2003-12-10 2005-06-16 Hans-Peter Podhaisky UV-stable, liquid or semisolid transdermal pharmaceutical preparation with light sensitive active ingredient
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
UA89766C2 (en) 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene
CA2549916C (en) 2003-12-12 2013-09-17 Schering Aktiengesellschaft Transdermal delivery system of hormones without penetration enhancers
JP4504109B2 (ja) 2004-06-15 2010-07-14 株式会社新陽社 画像表示装置及び画素構成体
EP1719504A1 (de) 2005-05-02 2006-11-08 Schering AG Festes transdermales therapeutisches System mit UV-Absorber
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
EP2349230A2 (en) 2008-10-06 2011-08-03 Mylan Technologies, Inc. Amorphous rotigotine transdermal system

Also Published As

Publication number Publication date
CY1105716T1 (el) 2010-12-22
ES2270345T3 (es) 2007-04-01
NO336108B1 (no) 2015-05-18
ATE333271T1 (de) 2006-08-15
SI1594483T1 (sl) 2006-12-31
EP1594483A1 (de) 2005-11-16
BRPI0407615B1 (pt) 2018-02-14
HRP20050828B1 (hr) 2013-10-25
US9095691B2 (en) 2015-08-04
IS2541B (is) 2009-09-15
DE502004000988D1 (de) 2006-08-31
RS50428B (sr) 2009-12-31
US8486443B2 (en) 2013-07-16
US20150335658A1 (en) 2015-11-26
ME00147B (me) 2010-10-10
AU2004212675A1 (en) 2004-09-02
US20060251707A1 (en) 2006-11-09
BRPI0407615A (pt) 2006-02-14
CR7952A (es) 2006-02-06
NZ541807A (en) 2009-07-31
MEP14008A (en) 2010-06-10
PL219030B1 (pl) 2015-03-31
WO2004073696A1 (de) 2004-09-02
CA2515918C (en) 2010-11-16
JP4528296B2 (ja) 2010-08-18
HRP20050828A2 (en) 2006-03-31
CA2515918A1 (en) 2004-09-02
EP1594483B1 (de) 2006-07-19
IL170295A (en) 2010-05-31
AR043248A1 (es) 2005-07-20
JP2006518348A (ja) 2006-08-10
ECSP056030A (es) 2006-01-27
KR100704825B1 (ko) 2007-04-09
PT1594483E (pt) 2006-12-29
PL378035A1 (pl) 2006-02-20
AU2004212675B2 (en) 2006-06-01
RS20050639A (en) 2007-09-21
HK1085394A1 (en) 2006-08-25
EA200501224A1 (ru) 2006-04-28
DK1594483T3 (da) 2006-11-20
BRPI0407615B8 (pt) 2021-05-25
EA008098B1 (ru) 2007-02-27
US20130226113A1 (en) 2013-08-29
MXPA05008778A (es) 2006-05-25
KR20050103499A (ko) 2005-10-31
PE20041028A1 (es) 2005-02-18
IS8031A (is) 2005-09-15
NO20054321L (no) 2005-09-20

Similar Documents

Publication Publication Date Title
UY28189A1 (es) Sistema terapéutico transdérmico estable a los rayos uv.
AR027091A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
ES2188648T3 (es) Copolimeros biodegradables y objetos de plastico que comprenden copo limeros biodegradables.
AR097045A2 (es) Sistema terapéutico transdérmico
PA8575701A1 (es) Preparaciones acidas de insulina con estabilidad mejorada
DE60029115D1 (de) Antigen enthaltende pharmazeutische zusammensetzung
CY1106468T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
DE69923786D1 (de) Dünner polymerfilm als medikamentenreservoir
EA200400866A1 (ru) Ламинированный инсектицидный диспенсер
DE60335557D1 (de) Pharmazeutische zusammensetzungen enthaltend ein opioidanalgetikum
ATE334656T1 (de) Flüssige pharmazeutische zusammensetzung
CY1107909T1 (el) Πολυστρωματικο δισκιο περιεχον ροσιγλιταζονη
DE69936195D1 (de) Pharmazeutische gelformulierung enthaltend eine trizyklische substanz (fk-506/tacrolimus)
ATE507831T1 (de) Melatonin enthaltende pharmazeutische formulierung
CL2004000877A1 (es) Combinacion farmaceutica que comprende 8a) melatonina y agonistas de la melatonina, y nicotina y agonistas receptores de nicotina; kit farmaceutico, y; uso en el tratamiento de insomnio, dificultades cognitivas y dificultades de memoria; kit farmaceu
CR9483A (es) Sistema terapeutico transdermico solido con absorbedor uv
CR8461A (es) Forma de administracion transdermica, liquida o semisolida que contiene sustancia activa sensible a la luz, estable a los rayos ultravioletas
CL2004000884A1 (es) Composicion farmaceutica en forma de hidrogel que contiene un diester de acido carbonico, un alquilalcohol c2-c4, por lo menos una sustancia activa y una matriz de polimero; uso en el tratamiento de carencias esteroidales.
DE60136367D1 (de) Pharmazeutische zusammensetzung mit modifiziertem träger
CU23518A3 (es) Sistema terapéutico transdérmico estable a los rayos ultravioletas
DE60217369D1 (de) Pharmazeutische zusammensetzung enthaltend gamma-butyrobetain
UY28667A1 (es) Forma de administración transdérmica, líquida o semisólida que contiene sustancia activa sensible a la luz, estable a los rayos ultravioletas.
CU20060115A7 (es) Forma de administración transdérmica, líquida o semisólida que contiene sustancia activa sensible a la luz, estable a los rayos ultravioletas
ITTO990935A0 (it) Sistema per lo sviluppo rapido in luce ambiente di film radiografici d entali che consente il recupero del liquido di trattamento esausto. il
ECSP003570A (es) Derivados de 2- bencil-3-dimetilamino-1-fenil- propano

Legal Events

Date Code Title Description
110 Patent granted

Effective date: 20150706